Angiotensin Type 1 Receptor Blocker Restores Podocyte Potential to Promote Glomerular Endothelial Cell Growth
Open Access
- 1 July 2006
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of the American Society of Nephrology
- Vol. 17 (7), 1886-1895
- https://doi.org/10.1681/asn.2005020205
Abstract
Both podocytes and glomerular endothelial cells (GEN) are postulated to play important roles in the progression and potential regression of glomerulosclerosis. Inhibition of angiotensin is crucial in treatment of chronic kidney disease, presumably via effects on BP and extracellular matrix. This study aimed to investigate how angiotensin inhibition altered the interactions between podocytes and GEN. The effects of supernatants from primary cultured mouse podocytes, before or after sublethal injury by puromycin aminonucleoside, in the presence or absence of angiotensin type 1 receptor blocker (ARB), on GEN sprouting and growth were assessed. Supernatant from normal podocytes significantly increased GEN sprouting, whereas puromycin aminonucleoside–injured podocyte supernatant decreased these GEN responses. These effects were linked to decreased vascular endothelial growth factor A (VEGF-A) and angiopoietin-1 (Ang-1) protein from injured podocytes. This downregulation of VEGF-A and Ang-1 protein was reversed when injured podocytes were treated with ARB. Inhibition of VEGF-A or Ang-1 prevented this restored response by ARB. Activation of intracellular kinases (p38, extracellular signal–regulated kinase, and AKT) was suppressed in GEN that were treated with medium from injured podocytes but restored by medium from ARB-treated injured podocytes. Therefore, injured podocytes are ineffective in promoting GEN sprouting, and this effect is reversed by ARB treatment of the injured podocyte. These data support the idea that ARB effects on podocytes may mediate capillary remodeling in vivo.Keywords
This publication has 48 references indexed in Scilit:
- AT-1 receptor antagonism modifies the mediation of endothelin-1, thromboxane A2, and catecholamines in the renal constrictor response to angiotensin IIKidney International, 2005
- Differential expression of collagen- and laminin-binding integrins mediates ureteric bud and inner medullary collecting duct cell tubulogenesisAmerican Journal of Physiology-Renal Physiology, 2004
- Isolation, culture, and characterization of endothelial cells from mouse glomeruliKidney International, 2004
- Vascular endothelial growth factor-mediated activation of p38 is dependent upon Src and RAFTK/Pyk2Oncogene, 2003
- Angiotensin II AT1-receptor induces biglycan in neonatal cardiac fibroblasts via autocrine release of TGFβ in vitroCardiovascular Research, 2003
- Vascular endothelial growth factor: a new player in the pathogenesis of renal fibrosisCurrent Opinion in Nephrology and Hypertension, 2003
- Vascular Endothelial Growth Factor Induction of the Angiogenic Phenotype Requires Ras ActivationJournal of Biological Chemistry, 2001
- Prospects for phosphoinositide 3-kinase inhibition as a cancer treatment.Endocrine-Related Cancer, 2001
- Angiopoietin growth factors and Tie receptor tyrosine kinases in renal vascular developmentPediatric Nephrology, 2001
- Additive Effects of Enalapril and Losartan in (mREN-2)27 Transgenic RatsHypertension, 1998